Goldman Sachs Veteran Joins Cannabis Investment Firm

April 11, 2018, CHICAGO–(BUSINESS WIRE)–Salveo Capital, an alternative investment firm specializing in the legalized cannabis space, today announced the appointment of Thomas Mazarakis as a Managing Partner. Mr. Mazarakis will work alongside Managing Partners Michael Gruber and Jeffrey Howard in overseeing strategic direction and will be responsible for portfolio management as well as scaling the firm and its operations.

Mr. Mazarakis, 47, has over 18 years of financial and investment experience. Most recently, Mr. Mazarakis served as a Managing Director at Goldman Sachs in London where he was head of the Fundamental Strategies Group, a department of research analysts within the securities division’s multi-billion dollar equity and credit businesses. Earlier in his career at Goldman Sachs, Mr. Mazarakis served as an Executive Director and led the retail/consumer sector team. Prior to his tenure at Goldman Sachs, Mr. Mazarakis spent two years at Citigroup in New York where he analyzed high yield and distressed industrial companies within the credit research department. Mr. Mazarakis received a Bachelor of Science in environmental engineering from Northwestern University and a MBA from the University of Michigan.

Tom is a seasoned financial professional who brings years of relevant experience and a strong track record to Salveo. We expect Tom’s fundamentals-driven research process and analytical background to add a significant level of rigor and diligence to the cannabis fund landscape. We are very much looking forward to Tom’s contributions to our portfolio companies, fund investors and the firm as a whole.

Michael C. Gruber, a Managing Partner of Salveo Capital

“We are thrilled to welcome Tom as we seek to build premier companies to help reshape the image of legalized cannabis,” added Jeffrey Howard, a Managing Partner of Salveo Capital. “As the legalized cannabis space continues to evolve, it is critical that we have the right people in place to help us capitalize on strategic investment opportunities. As an avid early-stage investor and advisor to high-growth companies who is knowledgeable and passionate about the industry, Tom is the ideal fit to support our mission and goals.”

I am excited to have the opportunity to join a well-regarded firm that is investing in and partnering with innovative companies and entrepreneurs within a unique and high-growth sector. Michael and Jeff have worked diligently in a short time frame to assemble a high-quality portfolio of companies that is performing very well and has significant upside potential. I look forward to working with the team and building on this momentum.

Thomas Mazarakis, Managing Partner

Salveo Capital’s primary investment focus is on high-growth, ancillary service providers to the cannabis industry – rather than more highly-regulated businesses that “touch the plant”. The firm is currently investing capital out of its first private equity fund (“Fund I”) and is targeting a $25 million close in mid-2018. Salveo is seeking to rapidly scale its platform with a goal of reaching $100 million of committed capital by 2019. Thus far, Salveo Capital has completed seven investments including Baker, Front Range Biosciences, Headset, Purissima, Hiku Brands (formerly Tokyo Smoke), Treez and Wurk. Legalized cannabis is a $9 billion market in North America and, according to industry research, is expected to reach an estimated $22 billion by 2020. From an international perspective, various countries around the world including Australia, Germany and Spain are legalizing marijuana, while others including Canada, Israel and The Netherlands are permitting exportation.

About Salveo Capital

Launched at the end of 2016, Salveo Capital is an alternative investment firm specializing in the legalized cannabis space, particularly ancillary businesses. Salveo Capital’s approach is to bring an institutional quality discipline to company vetting, investment structures and portfolio management. The Firm is committed to shaping the early-stage, yet rapidly growing, industry by providing funding and development to companies with the will and vision to be the future faces of legalized marijuana. As cannabis legalization spreads, Salveo Capital seeks to build long term sustainable companies and support innovative technologies, products and services to help address the unique requirements of the industry. The firm is based in Northbrook, Illinois, and with vertical industry executives and cannabis operating advisors across the country, including key markets of California and Colorado. For more information, please visit

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter